Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
North Carolina Medical Journal
  • Menu
  • Articles
    • Correspondence
    • Errata
    • From the NCIOM
    • Letters to the Editor
    • Original Research
    • Policy Forum: Columns
    • Policy Forum: Introduction
    • Policy Forum: Invited Commentaries & Sidebars
    • Policy Forum: Issue Brief
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Subscribe
  • COVID-19 Research
  • For Advertisers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

https://ncmedicaljournal.com/feed
P-ISSN 0029-2559
E-ISSN 2379-4313
Policy Forum: Invited Commentaries & Sidebars
Vol. 74, Issue 6, 2013November 01, 2013 EDT

Pharmacogenomic Testing and the Prospect of Individualized Treatment

Daniel E. Jonas, Roberta Wines,
Invited Commentarypharmacogenomic testingindividualized treatmentDaniel E. JonasRoberta Wines
https://doi.org/10.18043/ncm.74.6.485
North Carolina Medical Journal
Jonas, Daniel E., and Roberta Wines. 2013. “Pharmacogenomic Testing and the Prospect of Individualized Treatment.” North Carolina Medical Journal 74 (6): 485–93. https:/​/​doi.org/​10.18043/​ncm.74.6.485.

View more stats

Powered by Scholastica, the modern academic journal management system